The exercise ECG showed an abnormal result in 69 patients (50%) (STsegment depression ≥0.1mV and/or reproduction of the patient's usual symptoms). The ACH-test revealed abnormal coronary vasomotion (reproduction of the patient's symptoms, ischemic ECG shifts +/-diffuse distal spasm) in 87 patients (64%). Such a result was significantly more often found in patients with a pathologic exercise ECG than in those with a normal exercise ECG (50/69, 72%, vs 37/68, 54%, p=0.034). There were no other statistically significant differences between patients with and those without a pathologic exercise ECG. Conclusion: A pathologic exercise ECG does not represent a false negative finding in patients with angina and non-obstructed coronary arteries but is indicative of underlying microvascular disease. (HR 4.93, p=0.009), baseline atrial fibrillation (HR 1.96, 95% CI 1.12-3.43, p=0.02), tobacco use (HR 1.69, 95% CI 1.00-2.84, p=0.049 for exsmoking and HR 6.78, 95% CI 0.89-51.47, p=0.06 for active smoking), age (HR 1.58 per 5 year-increase, 95% CI 1.18-2.11, p=0.002), resting heart rate (HR 1.10 per 5 bpm-increase, 95% CI 1.00-1.22, p=0.05) and diastolic blood pressure (HR 0.97, 95% CI 0.94-0.99, p=0.01), as independent predictors of overall mortality. Conclusions: In this study, 4-years overall mortality was 23% among elderly patients with sCAD. Simple clinical variables can identify patients at higher risk of mortality.
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Usefulness of the baseline lymphocyte count to predict platelet reactivity during clopidogrel therapy in patients with stable angina pectoris Inflammation is one of the major factors affecting Platelet (PLT) function and PLT response to antiplatelet therapy. Routine Complete Blood Count (CBC) is a simple method for assessment of inflammatory status.Aim: Our aim was to investigate the predictive value of the preprocedural count of different types of white blood cells on PLT reactivity to Clopidogrel (CLO) in Stable Angina Pectoris (SAP) patients undergoing coronary artery stent implantation. Methods: Ninety consecutive patients with SAP after elective and successful (TIMI 3) Percutaneous Coronary Intervention (PCI) with stent implantation were enrolled into the study (F/M=35/55pts, age=65.1±9.3 years). The PLT function analysis was performed 24h after PCI with Clopidogrel (CLO) loading dose (600mg; baseline) and after one month of antiplatelet therapy (CLO 75mg daily, control). The PLT activity was assessed in a whole blood based on impedance aggregometry (adenosine diphosphate as the agonist; ADP test) using multiple electrode aggregometry (Multiplate, Dynabyte, Germany). Both the baseline and the control PLT tests were associated with the preprocedural CBC, including: Neutrophil (N), Lymphocyte (L), Eosynophil (E), Monocyte (M) count and the following ratios (R): N/LR, PLT/LR and PLT/NR. Results: Both the baseline and the control PLT test reactivity to ADP were significantly correlated with the L count (ADP1: r=0,422, p<0.001 and ADP2: r=0.36, p<0.001) and inversely correlated with the N/LR (ADP1: r=-0.221, p=0.036 and ADP2: r=-0.226, p=0.032). The PLT/LR or PLT/NR were not associated with PLT test results. Conclusion: Increased preprocedural lymphocyte count is significantly correlated with the platelet reactivity during clopidogrel therapy and predicts increased platelet reactivity to clopidogrel in stable coronary artery disease patients. Objective: To investigate T-786C polymorphism of eNOs gene in Ukrainian patients with CAD and relationship between this polymorphism and clinical presentation.
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Materials and methods:
We examined 120 patients with CAD, stable angina pectoris II-III functional class who had haemodinamically significant coronary artery (CA) stenosis on selective coronary angioventriculography (SCVG). Control group included 35 persons without morphologic and atherosclerotic CA pathology. Examination included assessment of ankle-brachial index (ABI), doppler ultrasound of lower extremities vessels and carotid arteries with evaluation of intima-media complex thickness (IMCT). Allele polymorphism of eNOs gene was assessed by polymerase chain reaction with electrophoretic scheme of result detection. Results and discussion: Genotyping T -786C polymorphism of eNOs gene in control group showed the following distribution of T/T, C/T and C/C genotypes: 45,7; 48,6 and 5,7%; in patients with CAD -37,5; 40,8 and 21,7%, respectively. We divided examined patients into two groups: 1st group -46 patients with T/T genotype, 2nd group -74 patients with C/C and C/T genotypes. Patients in 2nd group were more likely to have arterial hypertension (p<0,05) and CAD manifestation in younger age (p<0,05). Clinical signs of CAD before myocardial infarction were twice more frequent in the 2nd group compared with the 1st group (p<0,05). Patients in the 2nd group were more likely to have multivessel CAD and diffuse CA injury (p<0,05). IMCT was significantly higher in the 2nd group. Clinical signs of peripheral atherosclerosis in 2nd group were verified in younger age, and average value of ABI in this group was lower (p<0,05). Conclusions: Patients with CAD who carry C allele develop cardiovascular diseases morphologically related to atherosclerosis in a younger age. In patients with C-allele atherosclerotic injury of CA on SCVG is multivessel, and frequency of two or more vascular areas involvement is significantly higher. Background: Ischemic heart disease may, with the occurrence of acute events, deteriorate to myocardial dysfunction. Compensation mechanisms such as Ischemic Preconditioning (IP), a powerful intrinsic phenomenon of myocardial protection, can minimize the deleterious effects of events. Additionally, coronary artery disease (CAD) associated with diabetes mellitus is associated with worse outcomes. Although experimental studies have shown that diabetes interferes negatively with the development of IP, it's still unknown whether diabetes can influence the expression of IP in patients with chronic CAD. Objective: To evaluate and compare IP in chronic CAD patients with and without diabetes. Methods: Diabetic and non-diabetic patients with chronic, stable CAD and preserved left ventricular systolic function were submitted to two sequential exercise tests (SET) with 30-minute interval between them. Ischemic parameters were compared between diabetic and non-diabetic patients. Ischemic preconditioning was considered present when time to 1mm ST-segment deviation was greater in the second of two SETs. Tests were analyzed by two independent and experienced cardiologists. Results: From 160 CAD patients who underwent SETs, 112 patients developed IP compared with 48 patients who did not (P=0.0001). From all patients, 75 were diabetic (group 1) and 85 were non-diabetic patients (group 2). The two groups were similar in terms of main prognostic parameters, besides previous infarction and cholesterol profile. In group 1, 54 (72%) patients developed IP and in group 2, 58 (68.2%) patients developed IP (P=0.35). When we compared the two groups, the improvement in time to 1mm ST-segment deviation was quite similar (76 vs 66 seconds, respectively for groups 1 and 2; P=0.19). Improvement in time to the onset of angina during SETs were also similar between the groups (45.2 vs 76.7 seconds, respectively for groups 1 and 2; P=0.56).
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Conclusion:
In this study a significant number of diabetic and non-diabetic patients with coronary artery disease developed ischemic preconditioning. Additionally, diabetes mellitus appears not to have affected the magnitude of this protective mechanism.
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